Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.63 USD | +6.28% | +10.50% | +71.91% |
09/05 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
07/05 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.91% | 5.97B | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.50% | 21.93B | |
-12.15% | 22.34B | |
-7.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- IBRX Stock
- News ImmunityBio, Inc.
- Piper Sandler Adjusts ImmunityBio's Price Target to $10 From $20, Reiterates Overweight Rating